Finance

Beta
Lists
301015:SHE
Qingdao Baheal Medical Inc
CN¥20.35
-3.46%
(-0.73) 1D
Jun 8, 3:04:10 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301015...
Open
CN¥20.70
High
CN¥21.13
Low
CN¥20.07
Mkt. cap
11.08B
Avg. vol.
6.54M
Volume
3.93M
Dividend
2.81%
Quarterly dividend
CN¥0.14
Ex-dividend date
Jun 1, 2026
P/E ratio
20.93
52-wk high
CN¥32.38
52-wk low
CN¥18.80
EPS
CN¥0.97
Shares outstanding
525.62M
No. of employees
2K
Open
CN¥20.70
High
CN¥21.13
Low
CN¥20.07
Mkt. cap
11.08B
Avg. vol.
6.54M
Volume
3.93M
Dividend
2.81%
Quarterly dividend
CN¥0.14
Ex-dividend date
Jun 1, 2026
P/E ratio
20.93
52-wk high
CN¥32.38
52-wk low
CN¥18.80
EPS
CN¥0.97
Shares outstanding
525.62M
No. of employees
2K
News stories
From sources across the web
About Qingdao Baheal Medical Inc
CEO-
Employees2.49K
FoundedMar 8, 2005
Headquarters-
SectorHealth care provider
Websitebaheal.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.91B
1.88B
1.88B
1.78B
Cost of goods sold
1.24B
1.10B
1.22B
1.08B
Cost of revenue
1.24B
1.10B
1.22B
1.08B
Research and development expenses
12.49M
8.32M
15.93M
5.19M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
532.02M
346.64M
651.14M
458.58M
Operating expense
571.39M
349.86M
696.59M
474.96M
Total operating expenses
1.81B
1.45B
1.91B
1.55B
Operating income
101.78M
421.15M
-34.46M
229.28M
Other non operating income
3.66M
-11.29M
9.69M
-3.76M
EBT including unusual items
116.72M
435.32M
27.69M
193.58M
EBT excluding unusual items
75.08M
391.96M
-43.82M
198.79M
Income tax expense
14.97M
86.11M
16.37M
38.12M
Effective tax rate
12.83%
19.78%
59.13%
19.69%
Other operating expenses
29.52M
-8.78M
28.01M
7.60M
Net income
78.12M
313.29M
-1.74M
123.94M
Net profit margin
4.09%
16.70%
-0.09%
6.95%
Earnings per share
-
-
-
-
Interest and investment income
3.92M
2.92M
20.73M
1.77M
Interest expense
-26.61M
-28.49M
-26.92M
-28.50M
Net interest expenses
-22.69M
-25.57M
-6.18M
-26.73M
Depreciation and amortization charges
-
-
-
-
EBITDA
118.48M
433.99M
-17.16M
246.58M
Gain or loss from assets sale
-1.80K
1.80K
-520.33K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer